Insights into cytokine-receptor interactions from cytokine engineering

Jamie B Spangler1, Ignacio Moraga, Juan L Mendoza

  • 1Howard Hughes Medical Institute, Department of Molecular and Cellular Physiology, Department of Structural Biology, Stanford University School of Medicine, Stanford, California 94305; email: kcgarcia@stanford.edu , jamie.spangler@stanford.edu , imoraga@stanford.edu , juan.mendoza@stanford.edu.

Annual Review of Immunology
|December 11, 2014
PubMed

Insights

Protein engineering modifies cytokines to improve immunotherapeutic efficacy and reduce toxicity by enhancing target specificity. This approach offers new drug opportunities for cytokines like interferon and interleukins.

Area of Science:

  • Immunology
  • Protein Engineering
  • Drug Development

Background:

  • Cytokines are crucial for immune regulation but often cause toxicity or lack efficacy due to receptor pleiotropy and off-target effects.
  • Understanding cytokine-receptor interactions is key to developing targeted therapies.

Purpose of the Study:

  • To review the theory and practice of cytokine engineering.
  • To rationalize the mechanisms of engineered cytokines based on structure.
  • To highlight opportunities for engineered cytokines as immunotherapeutics.

Main Methods:

  • Structure-based protein engineering of cytokines.
  • Analysis of cytokine-receptor interactions.
  • Review of engineered cytokine examples (interferon, IL-2, IL-4).

Main Results:

  • Engineered cytokines can achieve narrowed target cell specificities, improving efficacy and reducing toxicity.
  • Protein engineering provides mechanistic insights into cytokine biology and signaling.
  • Structure-based design enables the development of novel cytokine-based drugs.

Conclusions:

  • Cytokine engineering is a powerful strategy for developing safer and more effective immunotherapies.
  • Targeted modification of cytokines like interferon, IL-2, and IL-4 holds significant therapeutic promise.
  • Further research into structure-function relationships will advance cytokine-based drug discovery.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
14.2K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
3.0K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
5.1K
Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
7.2K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
8.0K
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
89.6K